News & Updates

Show Multimedia Only

Rituximab shows promise in management of neuropsychiatric SLE

02 Jul 2024 by

Treatment with rituximab (RTX) in patients with moderate-to-severe neuropsychiatric (NP) systemic lupus erythematosus (SLE) appears to result in some improvements and to contribute to the use of a much lower steroid dose at 6 months, suggests a study presented at EULAR 2024.

02 Jul 2024

Cognitive remediation delivers sustained improvement in schizophrenia

30 Jun 2024

People with schizophrenia may benefit from cognitive remediation which offers durable improvements in both cognition and psychosocial functioning, as shown in a study.

30 Jun 2024

Is T1D protective against Parkinson’s disease?

24 Jun 2024 by

Researchers from Singapore found an association between type 1 diabetes (T1D) and Parkinson’s disease (PD) in a Mendelian randomization (MR) study.

24 Jun 2024

Extending givosiran use may help non–attack-free AHP patients achieve attack-free status

20 Jun 2024 by

Patients with AHP who do not achieve an attack-free status after the first 6 months of givosiran treatment can still benefit from further attack reductions and QoL improvements with continued treatment up to 36 months, according to the results from the ENVISION trial presented at EASL 2024

20 Jun 2024

Reduced-dose DOACs tied to lower stroke incidence vs warfarin

10 Jun 2024

Patients with atrial fibrillation receiving a reduced dose of direct acting oral anticoagulants (DOAC), particularly rivaroxaban and dabigatran, show a similar incidence of ischaemic stroke and systemic embolism to those receiving warfarin, a study has shown.

10 Jun 2024

CXCL13 in cerebrospinal fluid aids in neurosyphilis diagnosis

09 Jun 2024

Evaluation of CXCL13 concentration in cerebrospinal fluid (CSF) shows good diagnostic accuracy for neurosyphilis, according to the results of a systematic review and meta-analysis.

09 Jun 2024

High cognitive reserve may counter dementia risk

07 Jun 2024 by

High cognitive reserve appears to confer protection against dementia, even among people with genetic predisposition to dementia, according to a study.

07 Jun 2024

Increased practice of Chinese calligraphy strengthens brain network in older adults

07 Jun 2024 by

Increased practice of Chinese calligraphy strengthens brain network in older individuals who already practice the cognitive activity regularly and experienced subjective cognitive decline (SCD), a two-arm, parallel-design, assessor-blind, randomized controlled trial conducted by the Chinese University of Hong Kong (CUHK) has found.

07 Jun 2024

COVID-19 does mess with the brain even years after infection

06 Jun 2024 by

A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.

06 Jun 2024

Maternal DHA supplementation: Does it deliver brain benefits in very preterm infants?

04 Jun 2024 by

High-dose supplementation of docosahexaenoic acid (DHA) in breastfeeding mums did not improve behavioural functioning and neurodevelopmental outcomes at 5 years in children born very preterm. However, it may be of benefit to some subgroups of children, according to the results of the 5-year follow-up of a subgroup from the MOBYDIck* trial.

04 Jun 2024